The Academic Evidence on Value Investing

Benjamin Graham did not need a PhD to notice that cheap stocks tended to outperform expensive ones. But it took the academic establishment decades to formalize what practitioners had observed since the 1930s. Today, the 'value premium' is one of the most researched topics in all of finance, with hundreds of papers examining its existence, magnitude, and persistence. Yet the academic evidence tells a more nuanced story than either value evangelists or skeptics would have you believe.

What the Research Actually Shows

The foundational evidence comes from Fama and French (1992, 1993), who demonstrated that stocks with high book-to-market ratios ('value' stocks) outperformed stocks with low book-to-market ratios ('growth' stocks) by roughly 4-5% annually from 1963 to 1990. This finding has been replicated across virtually every developed market and most emerging markets. The value premium is not an American phenomenon — it appears in Japan, Europe, Australia, and dozens of other markets. It also appears across asset classes: value effects have been documented in bonds, currencies, and commodities.

However, the magnitude and consistency of the premium depend heavily on how you define value. Using price-to-book, the traditional academic measure, the premium has been substantially weaker since 2000, leading some researchers to argue that the intangible-heavy modern economy has rendered book value obsolete as a valuation anchor. When you use composite measures that incorporate earnings yield, cash flow yield, and sales-to-price, the value premium remains more robust. This measurement choice matters more than most investors realize — it is not just an academic quibble but a practical decision that determines whether your value strategy actually captures the premium.

Going Deeper: Where the Evidence Gets Complicated

The most honest assessment of the academic evidence is this: value works, but not consistently, not everywhere equally, and not for the simple reasons most people assume. The risk-based explanation — that value stocks are fundamentally riskier and therefore must offer higher returns — faces challenges. Value stocks do tend to underperform during recessions, but the magnitude of the premium is too large to be explained by rational risk compensation alone. The behavioral explanation — that investors systematically overpay for growth and glamour — has strong experimental support but is difficult to test directly in markets. The truth likely involves both mechanisms, plus a third often overlooked factor: institutional constraints that prevent large investors from fully exploiting the premium, allowing it to persist. Additionally, the value premium is highly regime-dependent — it tends to be strongest during economic recoveries and weakest during late-cycle growth-driven markets.

Practical Application

1. Use composite value metrics rather than relying on a single ratio. Combining earnings yield, free cash flow yield, and EV/EBITDA creates a more robust value signal than any single measure.
2. Pair value with quality filters. Academic research shows that 'cheap and good' dramatically outperforms 'cheap and bad.' Screening for low valuations among profitable, financially healthy companies captures the best of the value premium while avoiding value traps.
3. Set a realistic time horizon. Even in the strongest academic samples, the value premium required 3-5 year holding periods to manifest reliably. Shorter periods introduced significant variance.
4. Be aware of the current regime. After periods of extreme underperformance (like 2017-2020), value has historically snapped back aggressively. After periods of strong outperformance, moderate your expectations.

Screen for Academically-Backed Value

Put the academic evidence to work by screening for stocks that fit the value profile across multiple metrics simultaneously. Our value preset incorporates the composite approach that research suggests is most robust. Screen for value stocks now →